Paper8097634
Expression of the multidrug resistance-associated P-glycoprotein (P-170) in 59 cases of de novo acute lymphoblastic leukemia: prognostic implications.
Goasguen JE and 8 others. Blood, 1993. Cited by 246 papers, by iCite.
Cite this record
ConductScience Library. Expression of the multidrug resistance-associated P-glycoprotein (P-170) in 59 cases of de novo acute lymphoblastic leukemia: prognostic implications. Papers, record 8097634. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8097634
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Expression of the multidrug resistance-associated P-glycoprotein (P-170) in 59 cases of de novo acute lymphoblastic leukemia: prognostic implications.
- PubMed
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Drug Resistance | Major topic |
| Membrane Glycoproteins | Major topic |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | Major topic |
| ATP Binding Cassette Transporter, Subfamily B, Member 1 | |
| Adolescent | |
| Adult | |
| Antibodies, Monoclonal | |
| Antigens, CD | |
| Bone Marrow | |
| Burkitt Lymphoma | |
| Child | |
| Child, Preschool | |
| Female | |
| Humans | |
| Immunohistochemistry | |
| Immunophenotyping | |
| Karyotyping | |
| Male | |
| Neoplasm Proteins | |
| Prognosis | |
| Survival Analysis | |
| Time Factors |
Source PubMed
Comments and corrections2
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 7902138 | Low incidence of activity of P-glycoprotein (P-170) in de novo acute lymphoblastic leukemia determined by a flow cytometric assay. | https://conductscience.org/library/papers/7902138 | PubMed |
| Comment in | 7903172 | Expression of the multidrug resistance-associated P-glycoprotein (P-170) in acute lymphoblastic leukemia. | https://conductscience.org/library/papers/7903172 | PubMed |
Cited by31
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 246 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42064075 | TLR2 activation potentiates P-glycoprotein-mediated methotrexate efflux and enhances cytotoxicity of human NK cells against acute lymphoblastic leukemia. | Front Immunol | 2026 | https://conductscience.org/library/papers/42064075 | PubMed |
| 34985725 | A Systematic Review of Population Pharmacokinetic Models of Methotrexate. | Eur J Drug Metab Pharmacokinet | 2022 | https://conductscience.org/library/papers/34985725 | PubMed |
| 29236701 | Anti-leukemic activity of bortezomib and carfilzomib on B-cell precursor ALL cell lines. | PLoS One | 2017 | https://conductscience.org/library/papers/29236701 | PubMed |
| 28271337 | MicroRNAs as prognostic biomarker and relapse indicator in leukemia. | Clin Transl Oncol | 2017 | https://conductscience.org/library/papers/28271337 | PubMed |
| 27449773 | Profiling gene mutations, translocations, and multidrug resistance in pediatric acute lymphoblastic leukemia: a step forward to personalizing medicine. | Med Oncol | 2016 | https://conductscience.org/library/papers/27449773 | PubMed |
| 26354033 | Cytidine deaminase polymorphisms and worse treatment response in normal karyotype AML. | J Hum Genet | 2015 | https://conductscience.org/library/papers/26354033 | PubMed |
| 23292860 | Importance of detecting multidrug resistance proteins in acute leukemia prognosis and therapy. | J Clin Lab Anal | 2013 | https://conductscience.org/library/papers/23292860 | PubMed |
| 23100919 | Multidrug resistance 1 gene expression and AgNOR in childhood acute leukemias. | Indian J Hematol Blood Transfus | 2007 | https://conductscience.org/library/papers/23100919 | PubMed |
| 22942566 | Expression of P-glycoprotein, Cyclin D1 and Ki-67 in Acute Lymphoblastic Leukemia: Relation with Induction Chemotherapy and Overall Survival. | Indian J Hematol Blood Transfus | 2011 | https://conductscience.org/library/papers/22942566 | PubMed |
| 21070600 | Down-regulated miR-331-5p and miR-27a are associated with chemotherapy resistance and relapse in leukaemia. | J Cell Mol Med | 2011 | https://conductscience.org/library/papers/21070600 | PubMed |
| 20055093 | Development of idarubicin and doxorubicin solid lipid nanoparticles to overcome Pgp-mediated multiple drug resistance in leukemia. | J Biomed Nanotechnol | 2009 | https://conductscience.org/library/papers/20055093 | PubMed |
| 19369960 | Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cells. | Leukemia | 2009 | https://conductscience.org/library/papers/19369960 | PubMed |
| 17875533 | Expression of multidrug resistance 1 (MDR1), multidrug resistance-related protein 1 (MRP1), lung resistance protein (LRP), and breast cancer resistance protein (BCRP) genes and clinical outcome in childhood acute lymphoblastic leukemia. | Int J Hematol | 2007 | https://conductscience.org/library/papers/17875533 | PubMed |
| 17429427 | ABC transporters and drug resistance in leukemia: was P-gp nothing but the first head of the Hydra? | Leukemia | 2007 | https://conductscience.org/library/papers/17429427 | PubMed |
| 14574327 | Multidrug resistance genes in infant acute lymphoblastic leukemia: Ara-C is not a substrate for the breast cancer resistance protein. | Leukemia | 2004 | https://conductscience.org/library/papers/14574327 | PubMed |
| 11986955 | Pharmacokinetic interactions of cyclosporine with etoposide and mitoxantrone in children with acute myeloid leukemia. | Leukemia | 2002 | https://conductscience.org/library/papers/11986955 | PubMed |
| 11496948 | Mdr1 transfection causes enhanced apoptosis by paclitaxel: an effect independent of drug efflux function of P-glycoprotein. | Pharm Res | 2001 | https://conductscience.org/library/papers/11496948 | PubMed |
| 10958589 | Development of multidrug-resistance convertors: sense or nonsense? | Invest New Drugs | 2000 | https://conductscience.org/library/papers/10958589 | PubMed |
| 10455428 | A role for intracellular immunization in chemosensitization of tumor cells? | Gene Ther | 1999 | https://conductscience.org/library/papers/10455428 | PubMed |
| 9062400 | Indomethacin-mediated reversal of multidrug resistance and drug efflux in human and murine cell lines overexpressing MRP, but not P-glycoprotein. | Br J Cancer | 1997 | https://conductscience.org/library/papers/9062400 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ABCB1 | 5243 | PubTator's text mining | https://conductscience.org/library/genes/5243 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8097634
GET https://conductscience.org/api/papers/v1/8097634/cited_by?page=2